SCHEMBL6206783

SCHEMBL6206783

NC(=C(C(=O)O)C(=O)c1ccccc1)[N+](=O)[O-]

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 12/20 0.49
CES1 P23141 10/20 0.49
TSHR P16473 2/20 0.42
POLB P06746 1/20 0.42
CYP3A4 P08684 1/20 0.42
PARP1 P09874 1/20 0.42
MAPT P10636 1/20 0.42
CYP2C19 P33261 1/20 0.42
RECQL P46063 1/20 0.42
BLM P54132 1/20 0.42
PMP22 Q01453 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MAPK1 P28482 1/20 0.41
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
KMT2A Q03164 1/20 0.40
PRMT1 Q99873 1/20 0.40
VCAM1 P19320 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6207821 0.77 CES2 (0.56) CES2CES1TSHRPOLBCYP3A4
SCHEMBL6206793 0.75 CES2 (0.49) CES2CES1TSHRPOLBCYP3A4
SCHEMBL6206779 0.75 CES2 (0.49) CES2CES1TSHRPOLBCYP3A4
SCHEMBL6206786 0.75 CES2 (0.49) CES2CES1TSHRPOLBCYP3A4
SCHEMBL6206775 0.73 CES2 (0.52) CES2CES1TSHRPOLBCYP3A4
SCHEMBL6205112 0.73 CES2 (0.56) CES2CES1TSHRPOLBCYP3A4
SCHEMBL6207028 0.73 CES2 (0.52) CES2CES1TSHRPOLBCYP3A4
SCHEMBL6205634 0.73 CES2 (0.46) CES2CES1TSHRPOLBCYP3A4
SCHEMBL361897 0.72 CES2 (0.59) CES2CES1TSHRALDH1A1PRMT1
SCHEMBL5073645 0.71 CES2 (0.77) CES2CES1TSHRPOLBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1532128-A1 INHIBITORS OF HCV NS5B POLYMERASE Pharmacia & Upjohn Company LLC (US) 2005-05-25 EP disclosed
WO-2004002977-A1 INHIBITORS OF HCV NS5B POLYMERASE PHARMACIA & UPJOHN COMPANY LLC (US) 2004-01-08 WO disclosed